Welcome to Meheco, a pharmaceutical company dedicated to serving the public, caring for life, and striving for excellence. Beijing Meheco永正医药有限公司, a subsidiary of China General Technology Group, is a leading enterprise in Beijing's pharmaceutical business, established in March 1997 as the first pharmaceutical stock company registered with the Beijing Municipal Administration for Market Regulation and one of the first five pharmaceutical companies to pass the national GSP certification. Since joining China Medical, the company has experienced rapid development in sales and profitability, with its sales volume exceeding 40 billion yuan in 2019. The parent company, China General Technology (Group) Co., Ltd., is one of the 53 central enterprises primarily responsible for the trade sector, with core businesses in pharmaceutical healthcare, trade and engineering contracting, advanced manufacturing, and technical services consulting. It ranked 485th in the 2019 Fortune Global 500 list. Beijing Meheco永正医药有限公司 has a rich history of development, achieving a sales revenue of 33.10 billion yuan in 2018 and being acquired and controlled by China Medical in 2009. This H5 introduction was created using the online design services of Eqxiu.com, offering a wide range of templates for quick and efficient creation.